The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Mileson Glenna since 2021.
This trader's CIK number is 1822241.
At the time of last reporting, Mileson Glenna was the Chief Financial Officer of Athira Pharma, Inc.. (stock ticker symbol ATHA).
Also see all insider trading activities at Athira Pharma, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2022 | ATHA | 50,000 | $142,250 | 2,614 | $7,031 | 9,305 | $40,431 |
| 2021 | ATHA | 0 | $0 | 0 | $0 | 6,305 | $8,511 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2022-12-28 | ATHA | Buy | 50,000 | 2.85 | 142,250 |
| 2022-06-23 | ATHA | Sale | 2,614 | 2.69 | 7,031 |
| 2022-04-11 | ATHA | Option Ex | 3,000 | 10.64 | 31,920 |
| 2022-01-04 | ATHA | Option Ex | 6,305 | 1.35 | 8,511 |
| 2021-06-10 | ATHA | Option Ex | 6,305 | 1.35 | 8,511 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Mileson Glenna (Chief Financial Officer of Athira Pharma, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.